Dr. Ed Taub revolutionizes Stroke Rehab (BSP 119)
Ginger Campbell, Md and Edward Taub, Phd (click image to play audio)
I first talked with with Dr. Edward Taub the inventor of Constraint Induced (CI) Movement Therapy back in early 2008 (BSP 28). CI Therapy is a revolutionary rehabilitation method based on the principles of brain plasticity. Evidence supporting its effectiveness has mounted since we last talked. Unfortunately, because it is so different from traditional physical therapy, it requires special training and it is still not covered by many major insurance companies. The Veteran's Administration recognizes it as the preferred treatment for Traum...
Source: the Brain Science Podcast and Blog with Dr. Ginger Campbell - May 25, 2015 Category: Neuroscience Authors: Ginger Campbell, MD Tags: Brain Plasticity Interviews Neuroscience Podcast Show Notes Stroke Rehabilitation Source Type: podcasts
Imaging the Renal Mass: A Historical Review
ARTICLE DISCUSSED: Imaging the Renal Mass: A Historical Review; Radiology 2014:273(2):S126-S141. (Source: Radiology Podcasts)
Source: Radiology Podcasts - October 23, 2014 Category: Radiology Authors: webmaster at rsna.org Tags: Podcasts Source Type: podcasts
T-Cell Lymphoma Treatment and Research Update
Watch as Dr. Owen O’Connor gives us an overview of the state of treatment for T-Cell lymphoma and the latest news on emerging therapies. Despite a historical challenge in treating T-cell lymphomas, Dr...
Author: patientpower
Added: 09/24/2014 (Source: Oncology Tube)
Source: Oncology Tube - September 24, 2014 Category: Cancer & Oncology Source Type: podcasts
TWiV 297: Ebola! Don't panic
Hosts: Vincent Racaniello, Alan Dove, Rich Condit, and Kathy Spindler
The TWiVites present an all-ebolavirus episode, tackling virology, epidemiology, and approaches to prevention and cure that are in the pipeline.
Links for this episode
Risks and benefits of gain-of-function experiments (mBio)
Scientists for Science
US Policy for oversight of DURC (pdf)
US framework for guiding H5N1 transmission expts (pdf)
Extra oversight for H7N9 experiments (Science)
TWiV 283: No Reston for the weary
Is it Ebolavirus or Ebola virus? (virology blog)
Ebola virus disease update&...
Source: This Week in Virology - MP3 Edition - August 10, 2014 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
TWiV 280: Post viral
Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, Rich Condit, and Kathy Spindler
The TWiVmeisters answer listener email about the NEIDL, negative results, patenting MERS-coronavirus, human papillomavirus transmission, canine distemper virus, and much, much more.
Links for this episode
Poxvirus viability in historical relics (EID)
TWiM 74: It came from the Siberian permafrost
How to read a scientific paper
Image credit: Not only quilts
Letters read on TWiV 280
Weekly Science Picks
Alan - Heartbleed explanationVincent - Agriculture science today podcastKathy&n...
Source: This Week in Virology - MP3 Edition - April 13, 2014 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
Doing more by doing less!
Hepburn (band) (Photo credit: Wikipedia)
When I first heard of the book title ” Why Quitters Win: Decide to be excellent“, to say the least, I was very much intrigued. Was Nick trying to say something like stop doing something mid-way if you know that it is going to fail- and ignore the sunk costs…or was it about quitting when faced with unreasonable odds- rather than doubling your efforts and commitment. I believe in sticking with the choices you make, till you have given it your last shot, and so was slightly apprehensive.
However, what Nick Tasler means, is not about starting many things sequential...
Source: The Mouse Trap - October 11, 2013 Category: Psychiatrists and Psychologists Authors: sandygautam Tags: decision-making Quit Starbucks Source Type: podcasts
Christmas 2009
This year ’s Christmas podcast has a historical flavour. First of all, we will be hearing about the fate of a group of Norwegian seal hunters who met their end on Svalbard, in the Arctic Ocean. Ulf Aasebø and his team have redeemed their memories with a new explanation for their deaths.
We stick with sea v oyages, as John Hayman tells us about his... (Source: The BMJ Podcast)
Source: The BMJ Podcast - August 29, 2013 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
School Meals: Building Blocks for Healthy Children
This podcast provides a historical overview of the emergence of school meal programs and provides recommendations to update the nutrition standard and the meal requirements for the National School Lunch Program and School Breakfast Program. The recommendations reflect new developments in nutrition science, increase the availability of key food groups in the school meal programs, and allow these programs to better meet the nutritional needs of children, foster healthy eating habits, and safeguard children's health. Visit the IOM report page. (Source: The Sounds of Science from the National Academies)
Source: The Sounds of Science from the National Academies - August 31, 2010 Category: Science Authors: The National Academies Source Type: podcasts
ISCO and Absorption Sytems to Commercialize Stem Cell Derived Human Corneal Tissue for Drug Test
International Stem Cell Corporation (OTCBB:ISCO (www.internationalstemcell.com), the first company to perfect a method of creating human “parthenogenetic” stem cells from unfertilized eggs, has formed a partnership with Absorption Systems to utilize ISCO’s parthenogenetic stem cell-derived human corneal tissue to measure drug disposition, drug safety and drug-drug interactions. The collaboration between the companies is focused on using Absorption Systems’ know how in creating in vitro assay systems to develop a superior method of testing drugs that will also reduce the use of laborato...
Source: International Stem Cell Corporation - November 25, 2008 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine parthenogenesis stem cell Source Type: podcasts
ISCO and Absorption Sytems to Commercialize Stem Cell Derived Human Corneal Tissue for Drug Test
International Stem Cell Corporation (OTCBB:ISCO (www.internationalstemcell.com), the first company to perfect a method of creating human “parthenogenetic” stem cells from unfertilized eggs, has formed a partnership with Absorption Systems to utilize ISCO’s parthenogenetic stem cell-derived human corneal tissue to measure drug disposition, drug safety and drug-drug interactions. The collaboration between the companies is focused on using Absorption Systems’ know how in creating in vitro assay systems to develop a superior method of testing drugs that will also reduce the use of laboratory animals curren...
Source: International Stem Cell Corporation - November 25, 2008 Category: Stem Cells Authors: internationalstemcell Tags: biotechnology science health medicine parthenogenesis stem cell Source Type: podcasts
